Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Heart Repolarization
Interventions
DRUG

Naltrexone HCl/bupropion HCl

Naltrexone HCl/bupropion HCl extended-release tablet.

OTHER

Placebo

Naltrexone/bupropion placebo-matching tablets.

DRUG

Moxifloxacin

Moxifloxacin tablet.

Trial Locations (1)

Unknown

Austin

Sponsors
All Listed Sponsors
lead

Orexigen Therapeutics, Inc

INDUSTRY